Erez Aminov - 01 Oct 2025 Form 4 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role
Chief Executive Officer, Director
Signature
/s/ Erez Aminov
Issuer symbol
MIRA
Transactions as of
01 Oct 2025
Net transactions value
$0
Form type
4
Filing time
03 Oct 2025, 20:00:16 UTC
Previous filing
18 Sep 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Aminov Erez Chief Executive Officer, Director C/O MIRA PHARMACEUTICALS, INC., 1200 BRICKELL AVE. SUITE 1950 #1183, MIAMI /s/ Erez Aminov 03 Oct 2025 0001986112

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRA Common Stock Award +2,685,456 +318% 3,530,156 01 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 2,685,456 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc.